Crainio will initially be used by doctors tending to patients with TBI in the secondary care setting. In time we will look to make the technology available to all clinical staff (paramedics and primary care doctors) and then to the public to assess seriousness of mild to moderate head injuries.
Crainio is currently being developed as a medical device: clinical studies are being set up to demonstrate the clinical utility and accuracy of the technology with further engineering envisaged to enable CE marking accreditation. We envisage crainio being on the market in 2026.
The technology behind Crainio was invented by a team led by Professor Panicos Kyriacou at City, University of London in the UK. Crainio is a UK based company.
News from Crainio
Dr Tomas Abay received the Gold Metal for Engineering at the STEM for Britain awards held on March 9th, 2020, at the House of Commons.